{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:47:57Z","timestamp":1769147277800,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010679","name":"Pasteur Institute of Iran","doi-asserted-by":"crossref","award":["664"],"award-info":[{"award-number":["664"]}],"id":[{"id":"10.13039\/501100010679","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.biologicals.2016.06.006","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T16:36:43Z","timestamp":1469551003000},"page":"378-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens"],"prefix":"10.1016","volume":"44","author":[{"given":"Mohammad Reza","family":"Asadi Karam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehri","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeid","family":"Bouzari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2016.06.006_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1067\/mda.2003.7","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"49","author":"Foxman","year":"2003","journal-title":"Dis Mon"},{"key":"10.1016\/j.biologicals.2016.06.006_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mda.2003.8","article-title":"The etiology of urinary tract infection: traditional and emerging pathogens","volume":"49","author":"Ronald","year":"2003","journal-title":"Dis Mon"},{"issue":"Suppl.\u00a02","key":"10.1016\/j.biologicals.2016.06.006_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2362.2008.01986.x","article-title":"Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli","volume":"38","author":"Dhakal","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.biologicals.2016.06.006_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.mimet.2009.04.013","article-title":"Identification of uropathogenic Escherichia coli surface proteins by shotgun proteomics","volume":"78","author":"Walters","year":"2009","journal-title":"J\u00a0Microbiol Methods"},{"key":"10.1016\/j.biologicals.2016.06.006_bib5","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1586\/erv.12.36","article-title":"Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine","volume":"11","author":"Brumbaugh","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2016.06.006_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/599839","article-title":"A\u00a0live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli","volume":"200","author":"Billips","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2016.06.006_bib7","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1128\/IAI.00337-07","article-title":"Uropathogenic Escherichia coli outer membrane antigens expressed during urinary tract infection","volume":"75","author":"Hagan","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib8","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/IAI.72.5.2810-2816.2004","article-title":"Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses","volume":"72","author":"Cuadros","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib9","doi-asserted-by":"crossref","first-page":"e1000586","DOI":"10.1371\/journal.ppat.1000586","article-title":"Mucosal immunization with iron receptor antigens protects against urinary tract infection","volume":"5","author":"Alteri","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.biologicals.2016.06.006_bib10","first-page":"421486","article-title":"Immunization with the recombinant cholera toxin B fused to fimbria 2 protein protects against Bordetella pertussis infection","author":"Olivera","year":"2014","journal-title":"Biomed Res Int 2014"},{"key":"10.1016\/j.biologicals.2016.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00010-12","article-title":"FdeC, a novel broadly conserved Escherichia coli adhesin eliciting protection against urinary tract infections","volume":"3","author":"Nesta","year":"2012","journal-title":"MBio"},{"key":"10.1016\/j.biologicals.2016.06.006_bib12","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1128\/IAI.71.12.7164-7169.2003","article-title":"The siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidate","volume":"71","author":"Russo","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib13","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.vaccine.2012.12.059","article-title":"Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice","volume":"31","author":"Asadi Karam","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.biologicals.2016.06.006_bib14","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1086\/318857","article-title":"Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections","volume":"183","author":"Langermann","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2016.06.006_bib15","doi-asserted-by":"crossref","first-page":"16669","DOI":"10.1073\/pnas.0607898104","article-title":"Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract","volume":"104","author":"Lane","year":"2007","journal-title":"Proc Natl Acad Sci U. S. A"},{"key":"10.1016\/j.biologicals.2016.06.006_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1385\/IR:33:1:083","article-title":"Effects of flagellin on innate and adaptive immunity","volume":"33","author":"Honko","year":"2005","journal-title":"Immunol Res"},{"key":"10.1016\/j.biologicals.2016.06.006_bib17","first-page":"525","article-title":"Toll-like receptors and renal bacterial infections","volume":"31","author":"Vandewalle","year":"2008","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.biologicals.2016.06.006_bib18","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1016\/j.vaccine.2008.08.070","article-title":"New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin","volume":"26","author":"Bargieri","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.06.006_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/CVI.00333-08","article-title":"Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates","volume":"16","author":"Mizel","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrurol.2010.101","article-title":"Host-pathogen interactions in urinary tract infection","volume":"7","author":"Nielubowicz","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molimm.2012.11.002","article-title":"Assessment of immune responses of the flagellin (FliC) fused to FimH adhesin of Uropathogenic Escherichia coli","volume":"54","author":"Karam","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib22","first-page":"55","article-title":"Cloning of fimH and fliC and expression of the fusion protein FimH\/FliC from Uropathogenic Escherichia coli (UPEC) isolated in Iran","volume":"4","author":"Asadi","year":"2012","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib23","doi-asserted-by":"crossref","first-page":"7375","DOI":"10.1128\/IAI.73.11.7375-7380.2005","article-title":"Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum","volume":"73","author":"Arakawa","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/IAI.72.1.66-75.2004","article-title":"Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis","volume":"72","author":"Li","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molimm.2014.12.008","article-title":"Intranasal immunization with fusion protein MrpH.FimH and MPL adjuvant confers protection against urinary tract infections caused by uropathogenic Escherichia coli and Proteus mirabilis","volume":"64","author":"Habibi","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.vaccine.2006.08.013","article-title":"Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity","volume":"25","author":"Huleatt","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.06.006_bib27","first-page":"107","article-title":"Nasal immunization with the 40-kDa outer membrane protein of Porphyromonas gingivalis plus cholera toxin induces protective immunity in aged mice","volume":"55","author":"Cai","year":"2013","journal-title":"J\u00a0Oral Sci"},{"key":"10.1016\/j.biologicals.2016.06.006_bib28","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/IAI.00470-13","article-title":"Immunization with the yersiniabactin receptor, FyuA, protects against pyelonephritis in a murine model of urinary tract infection","volume":"81","author":"Brumbaugh","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib29","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.4049\/jimmunol.160.4.2000","article-title":"HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160","volume":"160","author":"VanCott","year":"1998","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib30","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2014.02.004","article-title":"Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: implication for designing novel mucosal MERS vaccines","volume":"32","author":"Ma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.06.006_bib31","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/S0264-410X(02)00302-X","article-title":"Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant","volume":"20","author":"Skeiky","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.06.006_bib32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.3390\/toxins6041397","article-title":"Immunogenicity of a West Nile virus DIII-cholera toxin A2\/B chimera after intranasal delivery","volume":"6","author":"Tinker","year":"2014","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.biologicals.2016.06.006_bib33","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.vaccine.2005.08.097","article-title":"Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection","volume":"24","author":"Singh","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.06.006_bib34","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0264-410X(02)00478-4","article-title":"B- and T-cell responses to the mycobacterium surface antigen PstS-1 in the respiratory tract and adjacent tissues. Role of adjuvants and routes of immunization","volume":"21","author":"Rodriguez","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2016.06.006_bib35","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1128\/JVI.77.10.5589-5597.2003","article-title":"Intranasal vaccination using interleukin-12 and cholera toxin subunit B as adjuvants to enhance mucosal and systemic immunity to human immunodeficiency virus type 1 glycoproteins","volume":"77","author":"Albu","year":"2003","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib36","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1128\/JVI.75.17.7956-7965.2001","article-title":"Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization","volume":"75","author":"Chen","year":"2001","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/CVI.05146-11","article-title":"Mucosal immunization with a Staphylococcus aureus IsdA-cholera toxin A2\/B chimera induces antigen-specific Th2-type responses in mice","volume":"18","author":"Arlian","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib38","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1128\/IAI.00174-10","article-title":"A\u00a0multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice","volume":"78","author":"Wieser","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib39","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.176.5.3080","article-title":"Antigen-specific responses accelerate bacterial clearance in the bladder","volume":"176","author":"Thumbikat","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib40","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijmm.2007.05.009","article-title":"Flagella allow uropathogenic Escherichia coli ascension into murine kidneys","volume":"298","author":"Schwan","year":"2008","journal-title":"Int J Med Microbiol"},{"key":"10.1016\/j.biologicals.2016.06.006_bib41","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.1128\/IAI.73.11.7657-7668.2005","article-title":"Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization","volume":"73","author":"Wright","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.biologicals.2016.06.006_bib42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mib.2013.01.005","article-title":"Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection","volume":"16","author":"Ulett","year":"2013","journal-title":"Curr Opin Microbiol"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616300380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105616300380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T10:16:49Z","timestamp":1692440209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105616300380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1045105616300380"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.06.006","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of flagellin and cholera toxin as adjuvants in intranasal vaccination of mice to enhance protective immune responses against uropathogenic Escherichia coli antigens","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2016.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}